2026 NPPES data Gynecologic Oncology Physician NPI 1235574401 MD
Verify on CMS →

MOLLY GREENWADE, MD

Gynecologic Oncology Physician in SPRINGFIELD, Missouri. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
150
Medicare Part D claims · 73 beneficiaries · Gynecologic Oncology Physician avg: 188
Generic prescribing
93%
generic claims · 7% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$750.57
31 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: MOLLY GREENWADE, MD is a Gynecologic Oncology Physician ([object Object]) practicing in SPRINGFIELD, Missouri with a Medicare Part D prescribing footprint of 150 claims across 73 beneficiaries — 7% brand-name prescribing . Industry payments of $750.57 across 31 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: MOLLY GREENWADE, MD filed 150 Medicare Part D claims in 2023 across SPRINGFIELD, Missouri. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board certification likely (heuristic — not verified)

MOLLY GREENWADE, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

MOLLY GREENWADE, MD at a glance

Quality data not reported

NPI registry status

Active

Issued 05/01/2013

NPI 1235574401

Primary specialty

Gynecologic Oncology Physician

Niche

1,360 US NPIs in this specialty

Medicare Part D claims

150 20% vs specialty avg

2023 prescription claims

Specialty avg: 188

Specialty distribution in Missouri

How Gynecologic Oncology Physician compares to other specialties among Missouri providers

Missouri providers

Gynecologic Oncology Physician share within Missouri

1. Gynecologic Oncology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Gynecologic Oncology Physician share within Missouri

Specialty board-certification context

Estimated specialty board-certified rate — Gynecologic Oncology Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Gynecologic Oncology Physician ABMS/AOA estimate

Est. board-certified rate (Gynecologic Oncology Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Gynecologic Oncology Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MOLLY GREENWADE, MD is a Gynecologic Oncology Physician provider practicing in SPRINGFIELD, Missouri, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: MD. NPI: 1235574401. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

MOLLY GREENWADE, MD appears in the CMS NPPES registry as a Gynecologic Oncology Physician provider holding MD credentials at 3850 S NATIONAL AVE STE 700, SPRINGFIELD, MO, 65807, with a listed phone of (417) 875-3000. NPI 1235574401 was issued on 05/01/2013. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what GREENWADE most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 150 prescription claims written by this provider, covering 73 Medicare beneficiaries and totaling roughly $44K in drug spend, split 7% brand-name and 93% generic by claim count, with an opioid prescribing rate of 34.0%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Gynecologic Oncology Physician is a narrow specialty nationwide, with 1,360 enrolled providers across 49 states and an average of 188 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

3850 S NATIONAL AVE STE 700
SPRINGFIELD, MO 65807

Provider Details

NPI 1235574401
Specialty Gynecologic Oncology Physician
Credentials MD
Gender Female
NPI Issued 05/01/2013

Hospital and facility affiliations

Facilities where MOLLY GREENWADE, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

LESTER E COX MEDICAL CENTERS
SPRINGFIELD, MO

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MOLLY GREENWADE, MD. Source: openpaymentsdata.cms.gov.

Total received

$751

Largest payer

GlaxoSmithKline, LLC.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Generic-heavy

MOLLY GREENWADE, MD — brand share 7.0%
Specialty average (est.)

7% brand-name claims vs 93% generic, on 150 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

150
Total Claims
$44K
Total Drug Cost
73
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
160
Total Day Supply
2,594
Brand vs Generic
7% brand / 93% generic
Brand Drug Cost
$43K
Generic Drug Cost
$1K
Opioid Claims
51 (34.0% rate)

Patient Demographics

Average Patient Age
71.1 years
Avg HCC Risk Score
1.57
Gender Split
100% female / 0% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Oxycodone Hcl
40
Cyclobenzaprine Hcl
16
Medroxyprogesterone Acetate
15
Letrozole
12

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Gynecologic Oncology Physician Overview

How MOLLY GREENWADE, MD fits within the Gynecologic Oncology Physician landscape nationally.

1,360
Gynecologic Oncology Physician Providers in US
49
States with Gynecologic Oncology Physician
188
Avg Claims per Provider

MOLLY GREENWADE, MD's 150 claims are below the specialty average of 188.

Nearby Gynecologic Oncology Physician Providers in Missouri

Other clinicians with the same primary specialty enrolled in Missouri, drawn from the same CMS NPPES roster as GREENWADE.

Compare Gynecologic Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is MOLLY GREENWADE, MD's specialty?
MOLLY GREENWADE, MD specializes in Gynecologic Oncology Physician and practices in SPRINGFIELD, Missouri. Credentials: MD.
How much does MOLLY GREENWADE, MD prescribe under Medicare Part D?
In 2023, MOLLY GREENWADE, MD wrote 150 Medicare Part D claims totaling $44K in drug costs for 73 beneficiaries.
Where is MOLLY GREENWADE, MD located?
MOLLY GREENWADE, MD is located at 3850 S NATIONAL AVE STE 700, SPRINGFIELD, MO, 65807. Phone: (417) 875-3000.
What is MOLLY GREENWADE, MD's NPI number?
MOLLY GREENWADE, MD's National Provider Identifier (NPI) is 1235574401, issued on 05/01/2013.
Does MOLLY GREENWADE, MD prescribe more brand-name or generic drugs?
MOLLY GREENWADE, MD's prescribing is 7% brand-name and 93% generic drugs by claim count, with $43K in brand drug costs.
Does MOLLY GREENWADE, MD prescribe opioids?
Yes, MOLLY GREENWADE, MD had 51 opioid claims in 2023 with an opioid prescribing rate of 34.0%.
How many Gynecologic Oncology Physician providers are there in the US?
There are 1,360 Gynecologic Oncology Physician providers across 49 states in the US. The average Gynecologic Oncology Physician provider writes 188 Medicare Part D claims per year.
What drugs does MOLLY GREENWADE, MD prescribe most often?
Based on 2023 Medicare Part D data, MOLLY GREENWADE, MD's most frequently prescribed drugs include Oxycodone Hcl, Cyclobenzaprine Hcl, Medroxyprogesterone Acetate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MOLLY GREENWADE, MD accept Medicare?
MOLLY GREENWADE, MD appears in CMS Medicare data with 150 Part D claims and 73 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MOLLY GREENWADE, MD's credentials?
MOLLY GREENWADE, MD's NPI is 1235574401 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology